Opening (9:36 AM ET), Midday (12:49 PM ET) and Closing (3:31 PM ET). Constitution V5.1. Inactivity day 15, floor 45.
Checks passed: buying power $620.00 equals unleveraged buying power $620.00 (F.2, F.5 clear). Cash non-negative. Unsettled funds $0.00 (Amendment D). No open orders. No trades today.
Energy-led rotation, tech and health care soft. Confidence medium: the energy move had no dated source (Art. 24). Opening: SPY -0.31%, QQQ -0.49%, IWM -0.59%, XLE +2.22%, XLV -0.79%, XLK -0.68%.
Amendment G at open: not met (worst sector XLV -0.79%).
| Ticker | Price | Day | P/E | Mean target | Est. score | Result |
|---|---|---|---|---|---|---|
| TCOM | $37.82 | -0.7% | 7.8 | $58.44 (+55%) | ~47 | Not proposed. Stale target, no catalyst (Art. 6.1, 10). |
| GSK | $46.51 | -1.1% | 15.8 | $58.33 (+25%) | ~46 | Not proposed. No catalyst (Art. 6.1, 7). |
| INCY | $112.95 | -0.4% | 15.9 | $131.00 (+16%) | ~47 | Not proposed. No catalyst (Art. 6.1, 7). |
| BMY | $59.22 | -0.8% | 14.0 | $65.83 (+11%) | ~47 | Not proposed (Art. 6.1, 10). |
| XOM | $168.49 | +2.7% | n/a | $173.17 (+3%) | <45 | Not proposed. Gap chase, unverified cause (Art. 22, 24). |
Discount-only setups with no verified catalyst. Escalation lowers the evidence threshold, not the evidence requirement (Art. 7).
Trigger 6 fired: Amendment G absolute level. XLV -1.69%, XLK -1.12%, XLU -1.11%. Triggers 1 to 5 did not fire: SPY -0.46% (0.15pp worse than open), GEV +0.95%, no halt or data anomaly, no macro event, and no dated resolution of the opening open questions. Full core run.
| Index / sector | vs 10/7 close | Index / sector | vs 10/7 close |
|---|---|---|---|
| SPY | -0.46% | XLE | +2.50% |
| QQQ | -0.91% | XLP | +1.58% |
| IWM | -0.77% | XLK | -1.12% |
| DIA | -0.25% | XLV | -1.69% |
| VOO | -0.45% | XLU | -1.11% |
Cause of the health care and tech weakness: two searches returned no dated same-day source, so the move may be sector-specific rather than macro (Art. 24, G.3).
| Ticker | Price | Day | Sector | vs 50-day | Result |
|---|---|---|---|---|---|
| BMY | $58.99 | -1.20% | XLV -1.69% | -8.3% | Falls less than sector (G.4 passes), but 8% under the 50-day with no support hold. G.5 fails. Est. ~47. Not proposed. |
| INCY | $111.18 | -1.99% | XLV -1.69% | -9.7% | Falls more than sector (G.4), below 50-day (G.5). Est. ~45. Not proposed. |
| GSK | $45.99 | -2.20% | XLV -1.69% | -8.6% | Falls more than sector (G.4), below 50-day (G.5). Est. ~45. Not proposed. |
| TCOM | $37.68 | -1.08% | n/a | -11.9% | At a fresh 52-week low, P/E 7.9, stale target, no catalyst. G.5 fails. Est. ~45. Not proposed. |
Qualified at 55 or above: 0. At or above the floor of 45 with a verified catalyst: 0. No threshold waived (G.6).
The one candidate falling less than its sector (BMY) had no technical support and an unverified cause. The rest fell more than their sector or sat at 52-week lows. A valuation discount without a catalyst is price-down logic (Art. 10, 22). GEV at midday: $1,006.57, +0.95%, thesis GREEN.
Tech and semis rout; energy and staples bid; financials up. Confidence medium-low: two searches returned no dated same-day cause (Art. 24). The midday health care and utilities weakness faded; the selloff narrowed to tech.
| Index / sector | vs 10/7 close | Index / sector | vs 10/7 close |
|---|---|---|---|
| SPY | -0.52% | XLE | +3.13% |
| QQQ | -1.51% | XLP | +2.22% |
| IWM | -0.08% | XLF | +1.00% |
| DIA | +0.06% | XLV | -0.52% |
| VOO | -0.52% | XLK | -2.03% |
Not met at open, met at midday and at close (XLK -2.03%, QQQ -1.51%). Dip screen run on tech: G.3, G.4, G.5 applied. Semis and AI-infra names fell more than the sector and fail G.4: ORCL -5.8%, ARM -7.2%, MU -5.0%, AVGO -4.8%, AMD -4.5%, LRCX -3.8%, NVDA -3.0%, AMAT -2.8%, WDC -2.8%.
| Ticker | Price | Day | P/E | Mean target | vs 50-day | Est. score | Result |
|---|---|---|---|---|---|---|---|
| MSFT | $521.96 | -1.47% | 29.5 | $582.40 (+11.6%) | +5.2% | ~49 | Falls less than XLK (G.4) and holds its 50-day (G.5). Verified catalyst: earnings 10/28. Not proposed: tech rout cause unverified and it bears on the AI-capex driver GEV already carries (Art. 24, 33, 8.2); thin edge; relative strength is supporting only (G.6). |
| QCOM | $175.08 | -1.15% | 20.5 | $196.73 (+12%) | +1.7% | ~44 | Down about 13% since 9/25, thin support (G.5). Not proposed. |
| CSCO | $115.16 | -1.90% | 35.3 | $138.43 (+20%) | +2.7% | ~44 | 35x is not cheap (Art. 6.4); no near catalyst. Not proposed. |
| BMY | $59.88 | +0.30% | ~13 | $65.83 (+10%) | below | ~47 | Recovered, no longer a dip, no catalyst. Not proposed (Art. 6.1, 10). |
| INCY | $113.13 | -0.27% | ~14 | $131.00 (+16%) | below | ~46 | Same. Not proposed. |
TXN (P/E 44) and PANW (P/E about 1,009) fail Art. 6.4 on valuation. Qualified at 55 or above: 0. At or above the floor of 45 with a verified catalyst: 1 (MSFT, rejected as above). No threshold waived. Article 6.4 applied to every name shown.
GREEN About $993.04, -0.41% today, holding up better than XLK and the semis; +$10.18 (+2.68%) on $380.00 cost. About 2.8% above the 50-day line ($966.27).
Three-way (Art. 34): Buy more, no (Art. 13, 21, 22; already 38.6%). Reduce or exit, no: mean target $1,206 (stale 7/22) is about 21% above price (Art. 6.4, 8.5, 10). Hold, affirmative (Art. 17). Earnings Oct 21; ex-dividend Oct 27.
MSFT was the closest call of the escalation period: it passed G.4 and G.5 with a verified catalyst, and scored about 49 against a floor of 45. It was held back because the tech and semis rout has no verified cause, the likely driver (AI capex) is the same one behind GEV, and the edge is thin. Escalation lowers the evidence threshold, not the evidence requirement (Art. 7). Cash at 61.4% is deliberate under Art. 3.3.
Next triggers: a dated cause for the tech rout; MSFT holding $496 (its 50-day) or pulling toward it before earnings on 10/28; a dated catalyst for BMY and INCY; JNJ, UNH, GS and JPM report 10/13; GEV earnings 10/21. Friday 10/9: Weekly Review, and the 10th dated log completes the archive batch.